Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Treatment Choices in Optic Neuritis: Corticosteroids, Intravenous Immunoglobulin, Plasma Exchange, or Other?
Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent.
Suppressed RNA-Polymerase 1 Pathway Is Associated with Benign Multiple Sclerosis.
Status spongiosus of CNS and hepatic changes induced by cuprizone (biscyclohexanone oxalyldihydrazone).
Gender and the hygiene hypothesis.
Positive results from Phase 3 CONFIRM clinical trial show efficacy and safety of oral BG-12 in multiple sclerosis
Delta-9-tetrahydrocannabinol/cannabidiol (sativex(®)): a review of its use in patients with moderate to severe spasticity due to multiple sclerosis.
Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study.
Age-related and cuprizone-induced changes in myelin and transcription factor gene expression and in oligodendrocyte cell densities in the rostral corpus callosum of mice.
Fcγ receptors in Norwegian multiple sclerosis patients and healthy controls.
Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response.
Cerebroside synthesis as a measure of the rate of remyelination following cuprizone-induced demyelination in brain.
Cigarette smoking and autoimmune disease: what can we learn from epidemiology?
Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence.
Synthetic Biologics Reports UCLA Announcement of Preliminary Positive Topline Efficacy and Safety Results from Investigator-Led Phase II Study of Trimesta™ for RRMS
Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding cuprizone.
Multiple sclerosis, vitamin D, and HLA-DRB1*15.
Mycophenolate mofetil in the treatment of multiple sclerosis: A preliminary report.
Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus.
Gene expression in brain during cuprizone-induced demyelination and remyelination.
Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders.
Cuprizone neurotoxicity in the rat: morphologic observations.
Cytokine profiles show heterogeneity of interferon-β response in multiple sclerosis patients.
Novartis drug Gilenya® shows long-term efficacy and safety according to new data from extension of phase III head-to-head study
Direct immunomodulatory influence of IFN-β on human astrocytoma cells.
Pages
« first
‹ previous
…
17
18
19
20
21
22
23
24
25
…
next ›
last »